Dose‐ And Administration Time‐Dependent Effects Of Nifedipine Gits On Ambulatory Blood Pressure In Hypertensive Subjects

References

• Anwar Y A, Giacco S, McCabe E J, Tendler B E, White W B. Evaluation of the efficacy of the Omron HEM‐737 Intellisense device for use on adults according to the recommendations of the Association for the Advancement of Medical Instrumentation. Blood Press. Monit. 1998; 3: 261–265
   PubMedGoogle Scholar
• Baumgart P. Circadian rhythm of blood pressure: internal and external triggers. Chronobiol. Int. 1991; 8: 444–450
   PubMed Web of Science ®Google Scholar
• Caruana M P, Lahiri A, Cashman P M, Altman D G, Raftery E B. Effects of chronic congestive heart failure secondary to coronary artery disease on the circadian rhythm of blood pressure and heart rate. Am. J. Cardiol. 1988; 62: 755–759
   PubMed Web of Science ®Google Scholar
• Defina L F, Bookstaver D A, Goldfinger M P, Coffey T A. Nifedipine gastrointestinal therapeutic system versus nifedipine coat‐core: comparison of efficacy via 24‐hour ambulatory blood pressure monitoring. Ann. Pharmacother. 1997; 31: 819–822
   PubMed Web of Science ®Google Scholar
• Fernández J R, Hermida R C. Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol. Int. 1998; 15: 191–204
   PubMed Web of Science ®Google Scholar
• Fernandez J R, Mojón A, Hermida R C. Comparison of parameters from rhythmometric models with multiple components on hybrid data. Chronobiol. Int. 2004; 21: 467–482
   Web of Science ®Google Scholar
• Fogari R, Malacco E, Tettamanti F, Gnemmi A E, Milani M. Evening vs. morning isradipine sustained release in essential hypertension: a double‐blind study with 24 h ambulatory monitoring. Br. J. Clin. Pharmacol. 1993; 35: 51–54
   PubMed Web of Science ®Google Scholar
• Greminger P, Suter P M, Holm D, Kobelt R, Vetter W. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Clin. Invest. 1994; 72: 864–869
   PubMedGoogle Scholar
• Grundy J S, Foster R T. The nifedipine gastrointestinal and therapeutic system (GITS): evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. J. Clin. Pharmacokinet. 1996; 30: 28–51
   Web of Science ®Google Scholar
• Guidelines Committee. European Society of Hypertension—European Society of Cardiology guiudelines for the management of arterial hypertension. J. Hypertens. 2003; 21: 1011–1053
   PubMed Web of Science ®Google Scholar
• Hansson L, Hedner T, Dahlöf B. Prospective randomized open blinded end‐point (PROBE) study. A novel design for intervention trials. Blood Press. 1992; 1: 113–119
   PubMedGoogle Scholar
• Hermida R C, Ayala D E. Sampling requirements for ambulatory blood pressure monitoring in the diagnosis of hypertension in pregnancy. Hypertension. 2003; 42: 619–624
   PubMed Web of Science ®Google Scholar
• Hermida R C, Smolensky M H. Chronotherapy of hypertension. Curr. Opin. Nephrol. Hypertens. 2004; 13: 501–505
   PubMed Web of Science ®Google Scholar
• Hermida R C, Ayala D E, Fernández J R, Mojón A, Alonso I, Calvo C. Modeling the circadian variability of ambulatorily monitored blood pressure by multiple‐component analysis. Chronobiol. Int. 2002a; 19: 461–481
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, Mojón A, López J E. Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 2002b; 20: 1097–1104
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, Fernández J R, Ruilope L M, López J E. Evaluation of the extent and duration of the “ABPM effect” in hypertensive patients. J. Am. Coll. Cardiol. 2002c; 40: 710–717
   PubMed Web of Science ®Google Scholar
• Hermida R C, Ayala D E, Calvo C. Administration time‐dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr. Opin. Nephrol. Hypertens. 2005; 14: 453–459
   PubMed Web of Science ®Google Scholar
• Holm S. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 1979; 6: 65–70
   Web of Science ®Google Scholar
• Ingelsson E, Björklund‐Bodegard K, Lind L, Arnlöv J, Sundström J. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA 2006; 295: 2859–2866
   PubMed Web of Science ®Google Scholar
• Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Ambulatory blood pressure and 10‐year risk of cardiovascular and noncardiovascular mortality. The Ohasama Study. Hypertension. 2005; 45: 240–245
   PubMed Web of Science ®Google Scholar
• Kitahara Y, Saito F, Akao M, Fujita H, Takahashi A, Taguchi H, Hino T, Otsuka Y, Kushiro T, Kanmatsuse K. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients. J. Cardiovasc. Pharmacol. 2004; 43: 68–73
   PubMed Web of Science ®Google Scholar
• Kohno I, Iwasaki H, Okutani M, Mochizuki Y, Sano S, Satoh Y, Ishihara T, Ishii H, Mukaiyama S, Ijiri H, Komori S, Tamura K. Administration‐time‐dependent effects of diltiazem on the 24‐hour blood pressure profile of essential hypertension patients. Chronobiol. Int. 1997; 14: 71–84
   PubMed Web of Science ®Google Scholar
• Leenen F HH. Clinical relevance of 24 h blood pressure control by 1,4‐dihydropyridines. Am. J. Hypertens. 1996; 9: 97S–104S
   PubMed Web of Science ®Google Scholar
• Lemmer B. Cardiovascular chronobiology and chronopharmacology. Biologic rhythms in clinical and laboratory medicine, Y Touitou, E Haus. Springer‐Verlag, BerlinGermany 1992; 418–427
   Google Scholar
• Lemmer B, Nold G, Behne S, Kaiser R. Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiol. Int. 1991; 8: 485–494
   PubMed Web of Science ®Google Scholar
• Lemmer B, Lüders S, Schrader J, Manfredini R, Portaluppi F, Nold G, Zuther P. Chronopharmacology of amlodipine in non‐dippers and dippers [abstract]. Naunyn Schmiedebergs Arch Pharmacol. 2003; 367(Suppl.1)R113–437
   Google Scholar
• Lubsen J, Wagener G, Kirwan B A, de Brouwer S, Poole‐Wilson P A, ACTION investigators. Effect of long‐acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial. J. Hypertens. 2005; 23: 641–648
   PubMed Web of Science ®Google Scholar
• Mancia G, Omboni S, Parati G. Twenty‐four hours ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT). J. Hypertens. 2002; 20: 545–553
   PubMed Web of Science ®Google Scholar
• Mansoor G A, White W B, McCabe E J, Giacco S. The relationship of electronically monitored physical activity to blood pressure, heart rate, and the circadian blood pressure profile. Am. J. Hypertens. 2000; 13: 262–267
   PubMed Web of Science ®Google Scholar
• Meilhac B, Mallion J M, Carre A, Chanudet X, Poggi L, Gosse P, Dallocchio M. Study of the influence of the time of administration on the antihypertensive effect and nitrendipine tolerance in mild to moderate essential hypertensive patients. Value of ambulatory recording of blood pressure on 24 hours. Therapie. 1992; 47: 205–210
   PubMed Web of Science ®Google Scholar
• Mengden T, Binswanger B, Gruene S. Dynamics of drug compliance and 24‐hour blood pressure control of once daily morning vs. evening amlodipine. J. Hypertens. 1992; 10(Suppl.4)S136
   Google Scholar
• Nissen S E, Tuzcu E M, Libby P, Thompson P D, Ghali M, Garza D, Berman L, Shi H, Buebendorf E, Topol E J. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004; 292: 2217–2225
   PubMed Web of Science ®Google Scholar
• Nold G, Strobel G, Lemmer B. Morning vs. evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press. Monit. 1998; 3: 17–25
   PubMedGoogle Scholar
• O'Brien E, Staessen J. Normotension and hypertension as defined by 24‐hour ambulatory blood pressure monitoring. Blood Press. 1995; 4: 266–282
   PubMedGoogle Scholar
• O'Brien E, Sheridan J, O'Malley K. Dippers and non‐dippers. Lancet. 1988; 13: 397
   Google Scholar
• O'Brien E, Asmar R, Beilin L, Imai Y, Mallion J M, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P, on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J. Hypertens. 2003; 21: 821–848
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24‐h blood pressure: the Ohasama study. J. Hypertens. 2002; 20: 2183–2189
   PubMed Web of Science ®Google Scholar
• Pickering T G. The clinical significance of diurnal blood pressure variations: dippers and nondippers. Circulation. 1990; 81: 700–702
   PubMed Web of Science ®Google Scholar
• Pickering T G, Hall J E, Appel L J, Falkner B E, Graves J, Hill M N, Jones D W, Kurtz T, Sheps S G, Roccella E J. Recommendations for blood pressure measurement in humans and experimental animals, Part 1: Blood pressure measurement in humans. Hypertension. 2005; 45: 142–161
   PubMed Web of Science ®Google Scholar
• Poole‐Wilson P A, Lubsen J, Kirwan B A, van Dalen F J, Wagener G, Danchin N, Just H, Fox K A, Pocock S J, Clayton T C, Motro M, Parker J D, Bourassa M G, Dart A M, Hildebrandt P, Hjalmarson A, Kragten J A, Molhoek G P, Otterstad J E, Seabra‐Gomes R, Soler‐Soler J, Weber S. Effect of long‐acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomized controlled trial. Lancet. 2004; 364: 849–857
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky M H. Circadian rhythm and environmental determinants of blood pressure regulation in normal and hypertensive conditions. In blood pressure monitoring in cardiovascular medicine and therapeutics, W B White. Humana Press, Totowa, NJ 2000; 79–118
   Google Scholar
• Portaluppi F, Montanari L, Ferlini M, Vergnani L, Bagni B, Degli Uberti E C. Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide. Eur. Heart J. 1992; 13: 990–996
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Vergnani L, Manfredini R, Degli Uberti E C, Fersini C. Time‐dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am. J. Hypertens. 1995; 8: 719–726
   PubMed Web of Science ®Google Scholar
• Qiu Y G, Chen J Z, Zhu J H, Yao X Y. Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate. Cardiovasc. Drugs Ther. 2003; 17: 335–341
   PubMed Web of Science ®Google Scholar
• Seki S, Taniguchi M, Ohsawa S, Koga A, Ito T, Kunoh M, Imamoto S, Miyazaki H, Takeda S, Iwano K, Satoh C, Kanae K, Mochizuki S. Chronobiological analysis by ambulatory blood pressure monitoring of the hyperbaric and hypobaric indexes for evaluation of the antihypertensive effect of long‐acting nifedipine. Circ. J. 2005; 69: 1249–1255
   PubMed Web of Science ®Google Scholar
• Shimada K, Kario K. Altered circadian rhythm of blood pressure and cerebrovascular damage. Blood Press. Monit. 1997; 2: 333–338
   PubMedGoogle Scholar
• Sica D A, Wilson D K. Sodium, potassium, the sympathetic nervous system, and the renin‐angiotensin system: impact on the circadian variability in blood pressure. Blood pressure monitoring in cardiovascular medicine and therapeutics, W B White. Humana Press, Totowa, NJ 2000; 171–190
   Google Scholar
• Smith D H, Neutel J M, Lacourciere Y, Kempthorne‐Rawson J. Prospective, randomized, open‐label, blinded‐endpoint (PROBE) designed trials yield the same results as double‐blind, placebo‐controlled trials with respect to ABPM measurements. J. Hypertens. 2003; 21: 1291–1298
   PubMed Web of Science ®Google Scholar
• Staessen J, Fagard R, Lijnen P, Thijs L, Vaa Hoof R, Amery A. Ambulatory blood pressure monitoring in clinical trials. J. Hypertens. 1991; 9(Suppl.1)S13–S19
   Google Scholar
• Staessen J A, Fagard R, Thijs L, Celis H, Arabidze G G, Birkenhager W H, Bulpitt C J, de Leeuw P W, Dollery C T, Fletcher A E, Forette F, Leonetti G, Nachev C, ÓBrien E T, Rosenfeld J, Rodicio J L, Tuomilehto J, Zanchetti A. Randomised double‐blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997; 350: 757–764
   PubMed Web of Science ®Google Scholar
• Staessen J A, Thijs L, Fagard R, ÓBrien E T, Clement D, de Leeuw P W, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J. Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282: 539–546
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Kuwajima I, Kanemaru A, Shimosawa T, Hoshino S, Sakai M, Matsushita S, Ueda K, Kuramoto K. The cardiac functional reserve in elderly hypertensive patients with abnormal diurnal change in blood pressure. J. Hypertens. 1992; 10: 173–179
   PubMed Web of Science ®Google Scholar
• Timio M, Venanzi S, Lolli S, Lippi G, Verdura C, Monarca C, Guerrini E. “Non‐dipper” hypertensive patients and progressive renal insufficiency: a three‐year longitudinal study. Clin. Nephrol. 1995; 43: 382–387
   PubMed Web of Science ®Google Scholar
• Toal C B. Formulation dependent pharmacokinetics—does the dosage form matter for nifedipine?. J. Cardiovasc. Pharmacol. 2004; 44: 82–86
   PubMed Web of Science ®Google Scholar
• Touitou Y, Smolensky M H, Portaluppi F. Ethics, standards and procedures of animal and human chronobiology research. Chronobiol. Int. 2006; 23: 1083–1096
   PubMed Web of Science ®Google Scholar
• Umeda T, Naomi S, Iwaoka T, Inoue J, Sasaki M, Ideguchi Y, Sato T. Timing for administration of an antihypertensive drug in the treatment of essential hypertension. Hypertension. 1994; 23(Suppl. 1)I211–I214
   PubMed Web of Science ®Google Scholar
• van de Borne P, Abramowicz M, Degre S, Degaute J P. Effects of chronic congestive heart failure on 24‐hour blood pressure and heart rate patterns: a hemodynamic approach. Am. Heart J. 1992; 123: 998–1004
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994; 24: 793–801
   PubMed Web of Science ®Google Scholar
• White W B, Mansoor G A, Pickering T G, Vidt D G, Hutchinson H G, Johnson R B, Noveck R. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am. J. Hypertens. 1999; 12: 806–814
   PubMed Web of Science ®Google Scholar
• Zanchetti A. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group. J. Hypertens. 1994; 12(Suppl. 5)S23–S27
   PubMedGoogle Scholar